To address the disruption in seminars & scientific interactions at the onset of the Covid-19 pandemic, nine NIDDK-sponsored Diabetes Research Centers (DRCs) and three Centers for Diabetes Translational Research (CDTRs) established a weekly Virtual Seminar series. Anyone can register for the seminars, which are free and open to the public (registration required).
Investigator Profile: Jing Hughes, MD, PhD
Dr. Jing Hughes is an Assistant Professor at the Washington University School of Medicine in St. Louis. She is a recipient of a NIH NIDDK Gateway Award for her project "Primary Cilia in Human Type 1 Diabetes" Dr. Hughes joins the Human Pancreas Analysis Consortium (HPAC).
Multiomics single-cell analysis of human pancreatic islets reveals novel cellular states in health and type 1 diabetes
Recent publication highlighting the unprecedented multimodal analysis of human pancreatic islets using four complementary single-cell techniques, scRNA-seq, CyTOF, spatial proteomic IMC, and immunofluorescence staining unmasked the role of exocrine ductal cells as antigen-presenting cells in human T1D.
100 Year Insulin Anniversary
To celebrate the 100 year anniversary of the discovery of human insulin the University of Toronto is hosting a free virtual meeting April 14-16, 2021. Additionally, they are sponsoring Trainee & Early Career Investigator Awards. Abstracts due March 1.
The Cellular Senescence Network (SenNet) aims to catalyze the development of a framework for mapping cellular senescence & its associated secretory phenotype at high resolution, to provide atlases of cellular senescence in multiple tissues and under diverse conditions and across the lifespan. Applications for the following are currently open:
* Tissue Mapping Center * Technology Development & Application
* Consortium Organization & Data Coordinating Center
Applications Due: March 22, 2021
The mission of the Human Islet Research Network (HIRN) is to
better understand how human beta cells are lost in
Type 1 Diabetes and to find innovative strategies to protect or
replace functional beta cell mass in diabetic patients.
